Alnylam Pharmaceuticals, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() AMLX
Amylyx Pharmaceuticals, Inc. |
$3.81 | $337.58 M | -0.86 | 123 |
![]() APLS
Apellis Pharmaceuticals, Inc. |
$18.12 | $2.28 B | -11.36 | 705 |
![]() BMRN
BioMarin Pharmaceutical Inc. |
$58.83 | $11.28 B | 26.62 | 3040 |
![]() BPMC
Blueprint Medicines Corporation |
$82.10 | $5.25 B | -76.73 | 649 |
![]() DAWN
Day One Biopharmaceuticals, Inc. |
$6.76 | $685.15 M | -6.63 | 181 |
![]() EXEL
Exelixis, Inc. |
$36.15 | $10.12 B | 20.54 | 1147 |
![]() HALO
Halozyme Therapeutics, Inc. |
$58.84 | $7.27 B | 17.15 | 350 |
![]() INCY
Incyte Corporation |
$57.75 | $11.18 B | 385 | 2617 |
![]() ISEE
IVERIC bio, Inc. |
$39.95 | $5.51 B | -22.44 | 163 |
![]() KRTX
Karuna Therapeutics, Inc. |
$329.83 | $12.60 B | -28.09 | 339 |
![]() KRYS
Krystal Biotech, Inc. |
$164.70 | $4.74 B | 55.08 | 275 |
![]() MDGL
Madrigal Pharmaceuticals, Inc. |
$308.01 | $6.80 B | -14.07 | 528 |
![]() PRQR
ProQR Therapeutics N.V. |
$1.15 | $120.47 M | -3.18 | 166 |
![]() RARE
Ultragenyx Pharmaceutical Inc. |
$34.98 | $3.28 B | -5.56 | 1294 |
![]() RETA
Reata Pharmaceuticals, Inc. |
$172.36 | $6.57 B | -66.29 | 321 |
![]() SGEN
Seagen Inc. |
$228.74 | $43.15 B | -57.19 | 3256 |
![]() UTHR
United Therapeutics Corporation |
$284.96 | $12.80 B | 11.56 | 1305 |
![]() WVE
Wave Life Sciences Ltd. |
$5.85 | $897.89 M | -8.36 | 287 |